Literature DB >> 28655773

Ectodysplasin A protein promotes corneal epithelial cell proliferation.

Sanming Li1,2,3, Jing Zhou1,2,3, Jinghua Bu1,2,3, Ke Ning1,2,3, Liying Zhang1,2,3, Juan Li1,2,3, Yuli Guo1,2,3, Xin He1,2,3, Hui He1,2,3, Xiaoxin Cai1,2,3, Yongxiong Chen1,2,3, Peter Sol Reinach4, Zuguo Liu1,2,3,5, Wei Li6,2,3,5.   

Abstract

The EDA gene encodes ectodysplasin A (Eda), which if mutated causes X-linked hypohidrotic ectodermal dysplasia (XLHED) disease in humans. Ocular surface changes occur in XLHED patients whereas its underlying mechanism remains elusive. In this study, we found Eda was highly expressed in meibomian glands, and it was detected in human tears but not serum. Corneal epithelial integrity was defective and the thickness was reduced in the early postnatal stage of Eda mutant Tabby mice. Corneal epithelial cell proliferation decreased and the epithelial wound healing was delayed in Tabby mice, whereas it was restored by exogenous Eda. Eda exposure promoted mouse corneal epithelial wound healing during organ culture, whereas scratch wound assay showed that it did not affect human corneal epithelial cell line migration. Epidermal growth factor receptor (EGFR), phosphorylated EGFR (p-EGFR), and phosphorylated ERK1/2 (p-ERK) were down-regulated in Tabby mice corneal epithelium. Eda treatment up-regulated the expression of Ki67, EGFR, p-EGFR, and p-ERK in human corneal epithelial cells in a dose-dependent manner. In conclusion, Eda protein can be secreted from meibomian glands and promotes corneal epithelial cell proliferation through regulation of the EGFR signaling pathway. Eda release into the tears plays an essential role in the maintenance of corneal epithelial homeostasis.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  EDA; Ectodysplasin A; cell proliferation; cornea; epidermal growth factor receptor (EGFR); epithelial cell; genetic disease; meibomian gland dysfunction

Mesh:

Substances:

Year:  2017        PMID: 28655773      PMCID: PMC5555198          DOI: 10.1074/jbc.M117.803809

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  X-linked anhidrotic (hypohidrotic) ectodermal dysplasia is caused by mutation in a novel transmembrane protein.

Authors:  J Kere; A K Srivastava; O Montonen; J Zonana; N Thomas; B Ferguson; F Munoz; D Morgan; A Clarke; P Baybayan; E Y Chen; S Ezer; U Saarialho-Kere; A de la Chapelle; D Schlessinger
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 2.  The Meibomian puzzle: combining pieces together.

Authors:  Igor A Butovich
Journal:  Prog Retin Eye Res       Date:  2009-08-04       Impact factor: 21.198

3.  Ocular and non-ocular manifestations of hypohidrotic ectodermal dysplasia.

Authors:  Pallavi Tyagi; Vipin Tyagi; Adnan A Hashim
Journal:  BMJ Case Rep       Date:  2011-04-01

4.  Meibomian Gland Absence Related Dry Eye in Ectodysplasin A Mutant Mice.

Authors:  Yen-Chiao Wang; Sanming Li; Xiaoxiao Chen; Baikai Ma; Hui He; Tingting Liu; Jingwen Yu; Liying Zhang; Yongxiong Chen; Zuguo Liu; Wei Li
Journal:  Am J Pathol       Date:  2015-11-25       Impact factor: 4.307

5.  Activation of epidermal growth factor receptor during corneal epithelial migration.

Authors:  J D Zieske; H Takahashi; A E Hutcheon; A C Dalbone
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

6.  Signaling and subcellular localization of the TNF receptor Edar.

Authors:  P Koppinen; J Pispa; J Laurikkala; I Thesleff; M L Mikkola
Journal:  Exp Cell Res       Date:  2001-10-01       Impact factor: 3.905

7.  Ectodysplasin is a collagenous trimeric type II membrane protein with a tumor necrosis factor-like domain and co-localizes with cytoskeletal structures at lateral and apical surfaces of cells.

Authors:  S Ezer; M Bayés; O Elomaa; D Schlessinger; J Kere
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

8.  The ectodermal dysplasia receptor activates the nuclear factor-kappaB, JNK, and cell death pathways and binds to ectodysplasin A.

Authors:  A Kumar; M T Eby; S Sinha; A Jasmin; P M Chaudhary
Journal:  J Biol Chem       Date:  2000-10-16       Impact factor: 5.157

9.  Regulation of hair follicle development by the TNF signal ectodysplasin and its receptor Edar.

Authors:  Johanna Laurikkala; Johanna Pispa; Han-Sung Jung; Pekka Nieminen; Marja Mikkola; Xiuping Wang; Ulpu Saarialho-Kere; Juan Galceran; Rudolf Grosschedl; Irma Thesleff
Journal:  Development       Date:  2002-05       Impact factor: 6.868

Review 10.  Dry eye as a mucosal autoimmune disease.

Authors:  Michael E Stern; Chris S Schaumburg; Stephen C Pflugfelder
Journal:  Int Rev Immunol       Date:  2013-02       Impact factor: 5.311

View more
  7 in total

1.  EGFR inhibitor AG1478 blocks the formation of 3D structures mainly through ERK signaling pathway in Matrigel-induced 3D reconstruction of eccrine sweat gland-like structures.

Authors:  Liyun Chen; Lijie Du; Lei Zhang; Sitian Xie; Xiang Zhang; Haihong Li
Journal:  J Mol Histol       Date:  2020-03-26       Impact factor: 2.611

Review 2.  Transgenic dry eye mouse models: powerful tools to study dry eye disease.

Authors:  Dan-Yi Qin; Li-Xiang Wang; Ying-Ping Deng
Journal:  Int J Ophthalmol       Date:  2022-04-18       Impact factor: 1.779

Review 3.  Epithelial-Mesenchymal Interaction in Hair Regeneration and Skin Wound Healing.

Authors:  Mei-Qi Mao; Jing Jing; Yu-Jie Miao; Zhong-Fa Lv
Journal:  Front Med (Lausanne)       Date:  2022-04-14

Review 4.  Ectodysplasin A (EDA) Signaling: From Skin Appendage to Multiple Diseases.

Authors:  Ruihan Yang; Yilan Mei; Yuhan Jiang; Huiling Li; Ruixi Zhao; Jian Sima; Yuyuan Yao
Journal:  Int J Mol Sci       Date:  2022-08-10       Impact factor: 6.208

5.  Engineered metal oxide nanomaterials inhibit corneal epithelial wound healing in vitro and in vivo.

Authors:  Soohyun Kim; Brooke Gates; Brian C Leonard; Megan Gragg; Kent E Pinkerton; Laura Van Winkle; Christopher J Murphy; Georgios Pyrgiotakis; Zhenyuan Zhang; Philip Demokritou; Sara M Thomasy
Journal:  NanoImpact       Date:  2019-12-06

Review 6.  Fetal gene therapy and pharmacotherapy to treat congenital hearing loss and vestibular dysfunction.

Authors:  Michelle L Hastings; John V Brigande
Journal:  Hear Res       Date:  2020-03-05       Impact factor: 3.208

7.  The EDA-deficient mouse has Zymbal's gland hypoplasia and acute otitis externa.

Authors:  Jorge Del-Pozo; Denis J Headon; James D Glover; Ali Azar; Sonia Schuepbach-Mallepell; Mahmood F Bhutta; Jon Riddell; Scott Maxwell; Elspeth Milne; Pascal Schneider; Michael Cheeseman
Journal:  Dis Model Mech       Date:  2022-03-30       Impact factor: 5.758

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.